Anabolic effect of dihydrotestosterone in testicular feminization syndrome.
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D013734:Androgen-Insensitivity Syndrome / Q000188:drug therapy / Q000378:metabolism*; D001835:Body Weight; D002369:Castration; D002467:Cell Nucleus / Q000187:drug effects; D003117:Color Vision Defects / Q000652:urine; D003404:Creatinine / Q000652:urine; D013196:Dihydrotestosterone / Q000494:pharmacology* / Q000627:therapeutic use; D004967:Estrogens / Q000652:urine; D005058:Eunuchism / Q000652:urine; D006801:Humans; D007006:Hypogonadism / Q000652:urine; D008607:Intellectual Disability / Q000652:urine; D008297:Male; D009584:Nitrogen / Q000652:urine; D000857:Olfaction Disorders / Q000652:urine; D010710:Phosphates / Q000652:urine; D011955:Receptors, Drug; D012729:Sex Chromosome Aberrations; D013268:Stimulation, Chemical; D013739:Testosterone / Q000494:pharmacology
D015068:17-Ketosteroids; D004967:Estrogens; D010710:Phosphates; D011955:Receptors, Drug; D013196:Dihydrotestosterone; D013739:Testosterone; D003404:Creatinine; D009584:Nitrogen